The use of survivorship care plans as a transition tool from the cancer center to primary care: an implementation science perspective to inform best practice.

使用幸存者护理计划作为从癌症中心到初级护理的过渡工具:从实施科学角度为最佳实践提供信息。

基本信息

项目摘要

The number of Canadians who live many years after cancer diagnosis and treatment is increasing. As a result, many cancer survivors are discharged from cancer centres, and receive their follow-up cancer care from their primary care provider (e.g., family p
在癌症诊断和治疗后生活多年的加拿大人的数量正在增加。因此,许多癌症幸存者从癌症中心出院,并接受初级保健提供者(例如家庭护理人员)的后续癌症护理

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lebel Sophie其他文献

Lebel Sophie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lebel Sophie', 18)}}的其他基金

Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
  • 批准号:
    488491
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
Living in limbo: The Experience of and Relationship between Fear of Progression, Illness Uncertainty, Symptom Burden, and Death Anxiety in Patients with Advanced or Metastatic Lung Cancer Receiving Immunotherapy or Targeted Therapy
生活在不确定之中:接受免疫治疗或靶向治疗的晚期或转移性肺癌患者对病情进展的恐惧、疾病的不确定性、症状负担和死亡焦虑的经历和关系
  • 批准号:
    478587
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
  • 批准号:
    484366
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
It is time to address fear of cancer recurrence in the family caregiver: a feasibility and acceptability study of an online version of the Fear Of Recurrence Therapy (FORT) for family caregivers.
现在是时候解决家庭护理人员对癌症复发的恐惧了:针对家庭护理人员的恐惧复发疗法 (FORT) 在线版本的可行性和可接受性研究。
  • 批准号:
    477304
  • 财政年份:
    2022
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
The University of Ottawa Fear of Cancer Recurrence International Colloquium
渥太华大学癌症复发恐惧国际研讨会
  • 批准号:
    325072
  • 财政年份:
    2015
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Miscellaneous Programs
Cognitive-Existential Intervention to address fear of recurrence in women with cancer
认知存在干预解决癌症女性对复发的恐惧
  • 批准号:
    182781
  • 财政年份:
    2009
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants

相似海外基金

Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
  • 批准号:
    488491
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
The effectiveness of a peer supporter led psychological care focusing on life values on psychological distress in cancer survivors
同伴支持者引导的心理护理的有效性,重点关注生命价值观对癌症幸存者心理困扰的影响
  • 批准号:
    23K12921
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
  • 批准号:
    10636699
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
  • 批准号:
    10736501
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
Defining Cognitive Patient Reported Outcomes of Breast Cancer Survivors in the Context of Everyday Functioning and Quality of Life
在日常功能和生活质量的背景下定义乳腺癌幸存者的认知患者报告结果
  • 批准号:
    10658037
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
  • 批准号:
    10911646
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
Intravaginal device for the treatment of pelvic pain and dyspareunia in female cancer survivors
用于治疗女性癌症幸存者盆腔疼痛和性交困难的阴道内装置
  • 批准号:
    10759026
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
Cognitive aging in long-term breast cancer survivors
长期乳腺癌幸存者的认知衰老
  • 批准号:
    10566264
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
A novel remote intervention to decelerate the age-related decline and disease development among older breast cancer survivors
一种新型远程干预措施,可减缓老年乳腺癌幸存者与年龄相关的衰退和疾病发展
  • 批准号:
    478415
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Operating Grants
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
基于互联网的生活方式干预,消除前列腺癌幸存者的肥胖虚弱 (iLIVE)
  • 批准号:
    10678740
  • 财政年份:
    2023
  • 资助金额:
    $ 7.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了